AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3531112 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy in air
Number of subjects: 104
Study 29424957 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 1002
Study 29424957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled results from both trials
Number of subjects: 1002
Study 27559057 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine duplex ultrasound surveillance (performed 2, 4, and 8 weeks postoperatively)
Number of subjects: 150
Study 27559057 — intervention group
Group type: COMPARATOR
Intervention: Selective duplex ultrasound (performed only when physical examination detected an abnormality)
Number of subjects: 150
Study 24825641 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 263
Study 24825641 — intervention group
Group type: COMPARATOR
Intervention: Control (no PET-CT)
Number of subjects: 263
Study 24825641 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized uptake value
Number of subjects: 263
Study 23279632 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/20 mg
Number of subjects: 808
Study 23279632 — intervention group
Group type: COMPARATOR
Intervention: doubling baseline statin (simvastatin 40 mg or atorvastatin 20 mg)
Number of subjects: 808
Study 23279632 — intervention group
Group type: COMPARATOR
Intervention: rosuvastatin 10 mg
Number of subjects: 808
Study 21930544 — intervention group
Group type: EXPERIMENTAL
Intervention: N-O-T+FIT (Not on Tobacco plus physical activity module)
Number of subjects: 233
Study 21930544 — intervention group
Group type: EXPERIMENTAL
Intervention: N-O-T (Not on Tobacco)
Number of subjects: 233
Study 21930544 — intervention group
Group type: COMPARATOR
Intervention: BI (Brief Intervention)
Number of subjects: 233
Study 19146131 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond (SB)
Number of subjects: 80
Study 19146131 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitremer (V)
Number of subjects: 80
Study 19146131 — intervention group
Group type: COMPARATOR
Intervention: FluroShield (F)
Number of subjects: 80
Study 19146131 — intervention group
Group type: COMPARATOR
Intervention: Helioseal Clear Chroma (H)
Number of subjects: 80
Study 19146131 — intervention group
Group type: COMPARATOR
Intervention: Fuji IX (FIX)
Number of subjects: 80
Study 19146131 — intervention group
Group type: COMPARATOR
Intervention: Clearfil Protect Bond (CF)
Number of subjects: 80
Study 19146131 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji II‐LC (FII)
Number of subjects: 80
Study 19146131 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac‐Molar (KM)
Number of subjects: 80
Study 16357545 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing intolerance index for ventilator users (n=11)
Number of subjects: 42
Study 16357545 — intervention group
Group type: COMPARATOR
Intervention: Breathing intolerance index for nonventilator users (n=31)
Number of subjects: 42
Study 16357545 — intervention group
Group type: COMPARATOR
Intervention: Breathing intolerance index for healthy controls (n=25)
Number of subjects: 42
Study 12803266 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube advanced into the right main bronchus
Number of subjects: 42
Study 12803266 — intervention group
Group type: COMPARATOR
Intervention: Standard tracheal intubation with a second endotracheal tube placed in the oesophagus
Number of subjects: 42
Study 10768799 — intervention group
Group type: EXPERIMENTAL
Intervention: High 5 school-based nutrition intervention
Number of subjects: 28
Study 8656254 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2
Number of subjects: 471
Study 8656254 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 135 mg/m2
Number of subjects: 471
Study 1613206 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifier (HH) (Draegger Aquaport)
Number of subjects: 116
Study 6433769 — intervention group
Group type: EXPERIMENTAL
Intervention: HB 420 (3.5 mg)
Number of subjects: 8
Study 6433769 — intervention group
Group type: COMPARATOR
Intervention: HB 419 (5 mg)
Number of subjects: 8
Study 30923521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ty21a vaccination
Number of subjects: 0
Study 30067074 — intervention group
Group type: EXPERIMENTAL
Intervention: GS100 (nonsystemic, orally administered hydrogel) co-administered with metformin
Number of subjects: 24
Study 30067074 — intervention group
Group type: EXPERIMENTAL
Intervention: GS100 co-administered with metformin
Number of subjects: 24
Study 27026335 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene treatment
Number of subjects: 50
Study 27026335 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 50
Study 25127988 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal CA-125 levels
Number of subjects: 38818
Study 25127988 — intervention group
Group type: COMPARATOR
Intervention: Normal CA-125 levels
Number of subjects: 38818
Study 22975086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (90-minute class with a registered dietitian/certified diabetes educator and twice keeping 3-day food records)
Number of subjects: 66
Study 22975086 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 66
Study 22975086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 66
Study 22975086 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 20074843 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution of BLS/AED manuals prior to the course (Group A)
Number of subjects: 303
Study 20074843 — intervention group
Group type: COMPARATOR
Intervention: No distribution of BLS/AED manuals prior to the course (Group B)
Number of subjects: 303
Study 20074843 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 303
Study 17522248 — intervention group
Group type: EXPERIMENTAL
Intervention: RC-1291, 50 mg qd for 6 days
Number of subjects: 29
Study 17522248 — intervention group
Group type: EXPERIMENTAL
Intervention: RC-1291, 75 mg qd for 6 days
Number of subjects: 29
Study 17522248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 16873952 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation (Q-Gel 120 mg) + 400 mg alpha-tocopherol + 250 mg vitamin C a day
Number of subjects: 41
Study 16873952 — intervention group
Group type: COMPARATOR
Intervention: Standard antiasthmatic therapy
Number of subjects: 41
Study 11904108 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine treatment (50 to 100 microg daily)
Number of subjects: 40
Study 11904108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11904108 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine treatment
Number of subjects: 40
Study 10453443 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected vegetables (SV) added to the daily diet of stage III and IV NSCLC patients (SVG group).
Number of subjects: 24
Study 10453443 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without selected vegetables (SV).
Number of subjects: 24
Study 10453443 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicity study group (TG) with selected vegetables (SV).
Number of subjects: 24
Study 7603598 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler studies
Number of subjects: 64
Study 7603598 — intervention group
Group type: COMPARATOR
Intervention: Standard duplex sonography
Number of subjects: 64
Study 7603598 — intervention group
Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 64
Study 2083404 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment at a dose of 3000 mg daily for 3 days
Number of subjects: 9
Study 2083404 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment
Number of subjects: 9
Study 2083404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7459899 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (CTX)
Number of subjects: 58
Study 7459899 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH)
Number of subjects: 58
Study 31605663 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (3 months of supervised aerobic and resistance exercise training, twice a week for 60 min)
Number of subjects: 50
Study 31605663 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (after withdrawal of supervised exercise)
Number of subjects: 50
Study 31605663 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 50
Study 31845228 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenqi Fuzheng Injection (SFI)
Number of subjects: 0
Study 31845228 — intervention group
Group type: COMPARATOR
Intervention: Cranial radiation alone (Control)
Number of subjects: 0
Study 28194877 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused breastfeeding counselling (intervention group)
Number of subjects: 3541
Study 28194877 — intervention group
Group type: COMPARATOR
Intervention: Usual care (reference group)
Number of subjects: 3541
Study 25820625 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular-stapled anastomosis (CSA)
Number of subjects: 238
Study 25820625 — intervention group
Group type: COMPARATOR
Intervention: Hand-sutured anastomosis (HSA)
Number of subjects: 238
Study 23467957 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine pericardial matrix (BPM)
Number of subjects: 40
Study 23467957 — intervention group
Group type: COMPARATOR
Intervention: Superficial musculoaponeurotic system (SMAS) flap
Number of subjects: 40
Study 21093066 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% silver nitrate cauterization
Number of subjects: 101
Study 21093066 — intervention group
Group type: COMPARATOR
Intervention: 95% silver nitrate cauterization
Number of subjects: 101
Study 19682490 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention program for mother-daughter dyads
Number of subjects: 916
Study 19682490 — intervention group
Group type: COMPARATOR
Intervention: Control group (test-only)
Number of subjects: 916
Study 19463378 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin alone (n = 2,284)
Number of subjects: 7789
Study 19463378 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GP IIb/IIIa inhibitor (control) (n = 2,189)
Number of subjects: 7789
Study 19463378 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin alone (n = 290)
Number of subjects: 7789
Study 19463378 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GP IIb/IIIa inhibitor (control) (n = 317)
Number of subjects: 7789
Study 19463378 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin alone
Number of subjects: 7789
Study 16261974 — intervention group
Group type: EXPERIMENTAL
Intervention: BMEKL assessment system
Number of subjects: 0
Study 16261974 — intervention group
Group type: COMPARATOR
Intervention: PULHEEMS assessment system
Number of subjects: 0
Study 12113884 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy cereal supplementation for 6 months
Number of subjects: 27
Study 12113884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 10446033 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 11
Study 10446033 — intervention group
Group type: COMPARATOR
Intervention: Conventional low-fat diet
Number of subjects: 11
Study 7884263 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet rich plasma (PRP)
Number of subjects: 191
Study 2378982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multiagent chemotherapy
Number of subjects: 58
Study 2378982 — intervention group
Group type: COMPARATOR
Intervention: No identified Ph chromosome (control group)
Number of subjects: 58
Study 2378982 — intervention group
Group type: EXPERIMENTAL
Intervention: POG frontline protocols for children with non‐T, non‐B‐cell ALL
Number of subjects: 58
Study 917457 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A therapy
Number of subjects: 9
Study 31253849 — intervention group
Group type: EXPERIMENTAL
Intervention: COSP intervention (n=50), 8 weekly sessions focused on coping skills
Number of subjects: 99
Study 31253849 — intervention group
Group type: EXPERIMENTAL
Intervention: COSP intervention (n=50)
Number of subjects: 99
Study 31253849 — intervention group
Group type: COMPARATOR
Intervention: Attention control (n=49), 8 weekly didactic education sessions
Number of subjects: 99
Study 31362556 — intervention group
Group type: EXPERIMENTAL
Intervention: Early plate fixation
Number of subjects: 178
Study 31362556 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 178
Study 28633819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mono-frequency ultrasound (MFU) at 20kHz
Number of subjects: 0
Study 28633819 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-frequency ultrasound (DFU)
Number of subjects: 0
Study 28633819 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-frequency ultrasound (TFU) at 20/35/50kHz
Number of subjects: 0
Study 28633819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound pretreatment (all types)
Number of subjects: 0
Study 25097088 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (50 mg)
Number of subjects: 200
Study 25097088 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (0.25 mg)
Number of subjects: 200
Study 25097088 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (50 mg) plus Magnesium sulfate (0.25 mg)
Number of subjects: 200
Study 25097088 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 200
Study 23051680 — intervention group
Group type: EXPERIMENTAL
Intervention: Home unattended portable monitoring and automatic CPAP titration
Number of subjects: 131
Study 23051680 — intervention group
Group type: COMPARATOR
Intervention: Attended in-laboratory analysis
Number of subjects: 131
Study 21743432 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (n=18) - received a 2 hour workshop on referral guidelines
Number of subjects: 37
Study 21743432 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=19) - received customary training in oral diagnosis
Number of subjects: 37
Study 18231111 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher experienced continuity of care
Number of subjects: 199
Study 18231111 — intervention group
Group type: COMPARATOR
Intervention: Transitions between phases of treatment
Number of subjects: 199
Study 16595460 — intervention group
Group type: EXPERIMENTAL
Intervention: Vastus-splitting approach
Number of subjects: 42
Study 16595460 — intervention group
Group type: COMPARATOR
Intervention: Median parapatellar approach
Number of subjects: 42
Study 14587168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lytic or combination therapy for patients less than 75 years of age in hospitals unable to perform early PCI.
Number of subjects: 0
Study 14587168 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy for patients older than 75 years unable to receive early PCI.
Number of subjects: 0
Study 14587168 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated PCI in centers where PCI is readily available after discussion with the local interventional cardiology team.
Number of subjects: 0
Study 14587168 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy using IIb/IIIa inhibitors plus fibrinolytics and/or LMWH.
Number of subjects: 0
Study 11040914 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac drops
Number of subjects: 52
Study 11040914 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen drops
Number of subjects: 52
Study 11040914 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops
Number of subjects: 52
Study 8790090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir, 400 mg, 5 times daily
Number of subjects: 50
Study 8790090 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 50
Study 8790090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 50
Study 1378138 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (ED50, 20-40 ng/min)
Number of subjects: 13
Study 1378138 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha (PGF2 alpha) (ED50, 480-1,170 ng/min)
Number of subjects: 13
Study 1378138 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 13
Study 1378138 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 13
Study 1378138 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (50 mg oral administration)
Number of subjects: 13
Study 1378138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 6090019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftizoxime (2 gm/day, administered intravenously)
Number of subjects: 47
Study 6090019 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole (4 gm/day, administered intravenously)
Number of subjects: 47
Study 30878496 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted shoulder rehabilitation therapy (30 minutes per day, 5 times per week for 4 weeks)
Number of subjects: 38
Study 30878496 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 38
Study 30541622 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-cognitive behavioural therapy digital 'informed choice' intervention
Number of subjects: 0
Study 30541622 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27653444 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg per day of azathioprine (AZA)
Number of subjects: 50
Study 27653444 — intervention group
Group type: COMPARATOR
Intervention: 2 mg/kg per day of azathioprine (AZA)
Number of subjects: 50
Study 25102532 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction during cystoscopy
Number of subjects: 45
Study 25102532 — intervention group
Group type: COMPARATOR
Intervention: Routine cystoscopy (Control)
Number of subjects: 45
Study 21392837 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist directed post‐discharge home medication review (n = 64, 53.3%)
Number of subjects: 120
Study 21392837 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 56, 46.7%)
Number of subjects: 120
Study 20194310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement group (Group 1)
Number of subjects: 130
Study 20194310 — intervention group
Group type: COMPARATOR
Intervention: Hybrid group (Group 2)
Number of subjects: 130
Study 18369656 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV with Oxane HD
Number of subjects: 20
Study 18369656 — intervention group
Group type: COMPARATOR
Intervention: PPV with 1300 cs silicone oil and scleral buckle
Number of subjects: 20
Study 16007042 — intervention group
Group type: EXPERIMENTAL
Intervention: Framon (0.25 mg/kg, intravenous bolus)
Number of subjects: 153
Study 11822956 — intervention group
Group type: COMPARATOR
Intervention: Postoperative enteral feeding with a standard diet within 12 hours of surgery (control group; n = 50)
Number of subjects: 150
Study 11822956 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid diet enriched with arginine, omega‐3 fatty acids, and RNA for 7 consecutive days (preoperative group; n = 50)
Number of subjects: 150
Study 11822956 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched liquid diet for 7 consecutive days followed by enteral feeding with the same enriched formula (perioperative group; n = 50)
Number of subjects: 150
Study 10365648 — intervention group
Group type: EXPERIMENTAL
Intervention: New cation-exchange HPLC method for plasma metformin determination
Number of subjects: 0
Study 8964631 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) before dialysis
Number of subjects: 12
Study 8964631 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) at the end of treatment
Number of subjects: 12
Study 8964631 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) 6 hours after dialysis
Number of subjects: 12
Study 8964631 — intervention group
Group type: EXPERIMENTAL
Intervention: On line BIA during hemodialysis
Number of subjects: 12
Study 2042756 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% glucose in lactated Ringer's solution (D2LR)
Number of subjects: 45
Study 2042756 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose in lactated Ringer's solution (D5LR)
Number of subjects: 45
Study 2042756 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution alone (LR)
Number of subjects: 45
Study 7040528 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate nasal aerosol (BDNA) 33.5 micrograms/burst (o.d., b.i.d., t.i.d., q.i.d.)
Number of subjects: 351
Study 7040528 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate nasal aerosol (BDNA) 42 micrograms/burst (b.i.d., q.i.d.)
Number of subjects: 351
Study 7040528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 30685114 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus Paclitaxel plus MEDI-575 (CPM)
Number of subjects: 99
Study 30685114 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus Paclitaxel (CP)
Number of subjects: 99
Study 28914978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) 12.5 mg/kg twice daily for EGT carrier children
Number of subjects: 0
Study 28914978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) 10.6 mg/kg twice daily for EGT noncarrier children
Number of subjects: 0
Study 27102361 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1500 mg/d BiocurcumaxTM)
Number of subjects: 96
Study 27102361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 24622805 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein (HP) infant formula
Number of subjects: 1090
Study 24622805 — intervention group
Group type: COMPARATOR
Intervention: Lower protein (LP) infant formula
Number of subjects: 1090
Study 22152230 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated Anxiety Learning and Management (CALM)
Number of subjects: 1004
Study 22152230 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1004